SEDG News

Four companies publicly listed on US markets during the last full week of the first quarter, raising $510 million. Solar tech provider SolarEdge outshined its peers while mega biotech Cellectis saw speculators jump in before the IPO and then quickly jump out. In the week ahead, GoDaddy (GDDY) is...read more

SolarEdge Technologies, which provides DC-optimized inverter systems for the solar industry, raised $126 million by offering 7 million shares at $18, the high end of its $16-$18 range. At $18, SolarEdge commands a fully diluted market cap of $778 million and an enterprise value of $644 million. SolarEdge Technologies will list on the NASDAQ under the symbol SEDG. Goldman Sachs and...read more

In the last full week of the first quarter, the IPO market could see a billion-dollar cancer biotech and a producer of optimized solar power technology. Three health care IPOs: a mega biotech and two small medical devices Pre-clinical immunotherapy biotech Cellectis (CLLS) is the...read more

SolarEdge Technologies, which provides DC-optimized inverter systems for the solar industry, announced terms for its IPO on Wednesday. The Herzilya, Israel-based company plans to raise $119 million by offering 7 million shares at a price range of $16 to $18. At the midpoint of the proposed range, SolarEdge Technologies would command a fully diluted market value of $733 million....read more